Rituximab in Chronic Inflammatory Demyelinating Polyneuropathy

NCT04480450 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Unable to acquire funding

Conditions

Interventions

Sponsor

University of Kansas Medical Center